The government has stepped in to save a tiny South African plant from extinction after hundreds of tons were harvested for foreign drug companies, one of which has patented its use to fight HIV/Aids. Now traditional healers, who have used the plant for centuries, are trying to win back the patent which they claim is rightfully theirs.
Currently, South African intellectual property legislation is highly fragmented, a situation that gives rise to a number of gaps and anomalies that undermine the rights of indigenous people. “Indigenous people” is not clearly defined by NEMBA or it Draft Regulations except to refer to such people as residing in a defined geographical area to which indigenous knowledge is found.
SUBMISSIONS TO THE DEPARTMENT OF ENVIRONMENTAL AFFAIRS AND TOURISM ON THE NATIONAL ENVIRONMENTAL MANAGEMENT: BIODIVERSITY ACT, 2004,: REGULATIONS ON BIOPROSPECTING, ACCESS AND BENEFIT SHARING.
SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB), BIOWATCH, AND EKOGAIA
GMPotatoesObjection.pdf Additional Comments and Objections to Continued Trials of GM Potatoes
African Centre for Biosafety, supported by various organisations, groups, companies, and individuals, Mar 2006
objection_bt_potato_g2_g3.pdf Objections to application for a permit for additional trials with insect resistant Bt Cry V Genetically Modified Potatoes (Solanum Tuberosum L. Variety ‘Spunta’ G2 and G3), as applied for by Dr G. Thompson, Director Plant Protection and Biotechnology , South African Agricultural Research Council, dated 24 May 2004 Download 157Kb
G. Ashton, G. Baker, M. Mayet, E. Pschorn-Strauss, W. Stafford, June 2004
Report2_Bt_Potato_G2G3.pdf Report 2003/2004 GMO Potato Project.
ARC-Roodeplaat, Vegetable and Ornamental Plant Institute and the Michigan State University (USA), made public in June 2004
1 Rights of Access to information severely prejudiced
The extensive deficiencies in the information supplied by the Applicant in response to our request for access to information in terms of the Promotion of Access to Information Act, 2000 (“PAIA”) coupled with the conflicting time frames provided by the Regulations under the Genetically Modified Organisms Act 15 of 1997 (“GMO Act” and those provided by PAIA, have severely restricted our rights to access